Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Allergy and Clinical Immunology
|
March 12, 2017
Circulating gluten-specific FOXP3<sup>+</sup>CD39<sup>+</sup> regulatory T cells have impaired suppressive function in patients with celiac disease
Laura Cook, C Mee Ling Munier, Nabila Seddiki, et al.
BMC Medicine
|
August 29, 2013
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways
Robert P Anderson, Margaret J Henry, Roberta Taylor, et al.
Science Advances
|
August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease
Gautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.
Frontiers in Immunology
|
June 7, 2021
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease
Melinda Y Hardy, Gautam Goel, Amy K Russell, et al.
Immunity
|
October 16, 2012
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease
Sophie E Broughton, Jan Petersen, Alex Theodossis, et al.
Nature Structural & Molecular Biology
|
April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease
Jan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
Gastroenterology
|
August 11, 2024
Gluten-Dependent Activation of CD4<sup>+</sup> T Cells by MHC Class II-Expressing Epithelium
Sara Rahmani, Heather J Galipeau, Alexandra V Clarizio, et al.
The Lancet. Gastroenterology & Hepatology
|
May 17, 2017
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies
Gautam Goel, Tim King, A James Daveson, et al.
Bioscience
|
December 23, 2024
Software codesign between end users and developers to enhance utility for biodiversity conservation
Mary E Blair, Elkin A Noguera-Urbano, Jose Manuel Ochoa-Quintero, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Allergy and Clinical Immunology
|
March 12, 2017
Circulating gluten-specific FOXP3<sup>+</sup>CD39<sup>+</sup> regulatory T cells have impaired suppressive function in patients with celiac disease
Laura Cook, C Mee Ling Munier, Nabila Seddiki, et al.
BMC Medicine
|
August 29, 2013
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways
Robert P Anderson, Margaret J Henry, Roberta Taylor, et al.
Science Advances
|
August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease
Gautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.
Frontiers in Immunology
|
June 7, 2021
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease
Melinda Y Hardy, Gautam Goel, Amy K Russell, et al.
Immunity
|
October 16, 2012
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease
Sophie E Broughton, Jan Petersen, Alex Theodossis, et al.
Nature Structural & Molecular Biology
|
April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease
Jan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
Gastroenterology
|
August 11, 2024
Gluten-Dependent Activation of CD4<sup>+</sup> T Cells by MHC Class II-Expressing Epithelium
Sara Rahmani, Heather J Galipeau, Alexandra V Clarizio, et al.
The Lancet. Gastroenterology & Hepatology
|
May 17, 2017
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies
Gautam Goel, Tim King, A James Daveson, et al.
Bioscience
|
December 23, 2024
Software codesign between end users and developers to enhance utility for biodiversity conservation
Mary E Blair, Elkin A Noguera-Urbano, Jose Manuel Ochoa-Quintero, et al.
Page
of 7